Banque Pictet & Cie’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
51,795
+15,170
| +41% | +$1.05M | 0.02% | 172 |
|
|
2025
Q1 | $2.54M | Buy |
36,625
+446
| +1% | +$31K | 0.02% | 191 |
|
|
2024
Q4 | $3.11M | Buy |
36,179
+14,437
| +66% | +$1.24M | 0.02% | 188 |
|
|
2024
Q3 | $2.59M | Buy |
21,742
+14,565
| +203% | +$1.73M | 0.02% | 172 |
|
|
2024
Q2 | $1.02M | Buy |
+7,177
| New | +$1.02M | 0.01% | 220 |
|
|
2023
Q4 | – | Sell |
-2,532
| Closed | -$230K | – | 412 |
|
|
2023
Q3 | $230K | Hold |
2,532
| – | – | ﹤0.01% | 413 |
|
|
2023
Q2 | $205K | Hold |
2,532
| – | – | ﹤0.01% | 468 |
|
|
2023
Q1 | $201K | Sell |
2,532
-2,900
| -53% | -$231K | ﹤0.01% | 556 |
|
|
2022
Q4 | $368K | Buy |
+5,432
| New | +$368K | ﹤0.01% | 544 |
|
|
2017
Q2 | – | Sell |
-26,228
| Closed | -$452K | – | 376 |
|
|
2017
Q1 | $452K | Buy |
+26,228
| New | +$452K | 0.01% | 283 |
|